2023 annual financial data
BriaCell Therapeutics 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -23,272,264 USD and net income was -20,302,394 USD.
Operating cash flow was -23,744,860 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -23,272,264 USD
- Net income
- -20,302,394 USD
- Operating cash flow
- -23,744,860 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all BriaCell Therapeutics financial years